SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Intellectual property and chirality of drugs
0 references·3 citing·8 second hop
Intellectual property and chirality of drugs (1999)Intellectual property and chirality of dr…The strategy of enantiomer patents of drugs (2010)The strategy of enantiomer pa…A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States (2008)A consideration of the patent…Brevet et autres moyens de protection des inventions pharmaceutiques (2004)Brevet et autres moyens de pr…Obituary: G. EMRYS HARRIES, M.B., B.S., D.P.H (1960)Longer Patents for Increased Generic Competition in the US (1996)The price of innovation: new estimates of drug development costs (2003)Returns to R&D on new drug introductions in the 1980s (1994)New drug approvals for 2002 (2003)Secondary Patenting Of Branded Pharmaceuticals: A Case Study Of How Patents On Two HIV Drugs Could Be Extended For Decades (2012)The predicated demise of racemic new molecular entities is an exaggeration (2012)Chiral Switch: Between Therapeutical Benefit and Marketing Strategy (2022)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2010The strategy of enantiomer patents of drugs61 cited
  • 2008A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States16 cited
  • 2004Brevet et autres moyens de protection des inventions pharmaceutiques4 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work